1. Home
  2. OSUR vs SENS Comparison

OSUR vs SENS Comparison

Compare OSUR & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OraSure Technologies Inc.

OSUR

OraSure Technologies Inc.

HOLD

Current Price

$4.07

Market Cap

295.7M

Sector

Health Care

ML Signal

HOLD

Logo Senseonics Holdings Inc.

SENS

Senseonics Holdings Inc.

HOLD

Current Price

$4.88

Market Cap

301.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSUR
SENS
Founded
2000
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
295.7M
301.2M
IPO Year
2000
2014

Fundamental Metrics

Financial Performance
Metric
OSUR
SENS
Price
$4.07
$4.88
Analyst Decision
Hold
Strong Buy
Analyst Count
2
4
Target Price
$3.00
$18.38
AVG Volume (30 Days)
448.1K
781.4K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$167,064,000.00
$16,389,000.00
Revenue This Year
$4.48
$74.15
Revenue Next Year
$7.76
$58.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.85
52 Week Low
$2.08
$0.41
52 Week High
$4.58
$8.75

Technical Indicators

Market Signals
Indicator
OSUR
SENS
Relative Strength Index (RSI) 48.63 33.79
Support Level $3.89 $4.79
Resistance Level $4.56 $5.94
Average True Range (ATR) 0.17 0.25
MACD -0.05 -0.01
Stochastic Oscillator 50.36 13.72

Price Performance

Historical Comparison
OSUR
SENS

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.

Share on Social Networks: